Determining the Frequency of Pathogenic Yeasts in Clinical Urine Samples and Tracking the Trichosporon Using Gold Nanoparticles

Document Type : Original Article(s)

Authors

1 MSc Student of Medical Mycology, Department of Mycology and Parasitology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Professor, Department of Mycology and Parasitology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

10.48305/jims.v42.i766.369

Abstract

Background: Timely identification and treatment of trichosporonosis is consequential due to the severity of pathogenesis and different therapies for candidiasis and its high mortality. In this study, in addition to determining the abundance of this fungus in clinical urine samples using past experiences in the function of gold nanoparticles, identification of this yeast based on serological methods for rapid detection of yeast in urine samples has been presented.
Methods: 249 samples of people suspected of urinary fungal infection were analyzed using morphological and molecular PCR-RFLP methods. Antigenic suspension was prepared from different species of Trichosporon. This mixture was injected with a complete adjuvant to a healthy rabbit. After injecting four booster doses using incomplete adjuvant, blood was drawn from the rabbit. The anti-fungal antibody ability in the rabbit serum was confirmed using the ELISA method. Then, the antibody was placed chemically on the surface of gold nanoparticles, and the method's performance was investigated.
Findings: C. glabrata and C. albicans species were the most common yeasts isolated. Among isolated yeasts, four cases of Trichosporon in urinary samples (1.6%) were reported. In this study, diabetes and corona disease were the underlying factors, and similar studies confirm the role of these factors. The serological method based on gold nanoparticles has been used in other studies to detect pathogens.
Conclusion: The frequency of trichosporon in urine was 1.6% during the study period. In this study, diabetes and Coronavirus disease were the main predisposing factors, and similar studies confirm the role of these factors. The serological method based on gold nanoparticles has been used in other studies to detect pathogens.

Highlights

Hossein Yousofi Daran:  Google Scholar, PubMed

Parvin Dehghan: Google Scholar, PubMed

Keywords

Main Subjects

References

  1. Lima YP, Dias VC. Trichosporon spp.: what’s new? Future Microbiol 2024; 19(5): 373-5.
  2. Kourti M, Roilides E. Invasive trichosporonosis in neonates and pediatric patients with malignancies or hematologic disorders. Pathogens 2022; 11(2): 242.
  3. Mukherjee DN, Seal S. P279 Invasive Trichosporonosis: an emerging blood stream fungal infection in immunocompromised patients. Medical Mycology 2022; 60(Suppl1): myac072P279.
  4. Ramírez I, Moncada D. Fatal disseminated infection by

    Trichosporon asahii under voriconazole therapy in a patient with acute myeloid leukemia: A review of breakthrough infections by Trichosporon spp. Mycopathologia 2020; 185(2): 377-88.
  5. Barantsevich N, Barantsevich E. Diagnosis and treatment of invasive candidiasis. Antibiotics (Basel) 2022; 11(6): 718.
  6. Li H, Guo M, Wang C, Li Y, Fernandez AM, Ferraro TN, et al. Epidemiological study of Trichosporon asahii infections over the past 23 years. Epidemiol

    Infect 2020; 148: e169.
  7. Bourusly MJ, Adel Obaid M, Burahma M. Successful treatment of trichosporon asahii infection with combinationtherapy of voriconazole and liposomal amphotericin B in a child with acute lymphoblastic leukemia: a case report. Int J Med Invest 2022; 11(2): 157-66.
  8. Malacrida AM, Corrêa JL, Barros ILE, Veiga FF, Pereira EdCA, Negri M, et al. Hospital Trichosporon asahii isolates with simple architecture biofilms and high resistance to antifungals routinely used in clinical practice. J Mycol Med 2023; 33(2): 101356.
  9. Wongsuk T, Boonsilp S, Pumeesat P, Homkaew A, Sangsri T, Chongtrakool P. Genotyping, antifungal susceptibility testing, and biofilm formation of Trichosporon spp. isolated from urine samples in a University Hospital in Bangkok, Thailand. Acta Microbiol Immunol Hung 2022; 69(3): 247-57.
  10. Mehta V, Nayyar C, Gulati N, Singla N, Rai S, Chandar J, et al. A comprehensive review of Trichosporon spp.: an invasive and emerging fungus. Cureus 2021; 13(8): e17345.
  11. Kianipour S, Ardestani ME, Dehghan P. Identification of Candida albicans and Candida dubliniensis species Isolated from bronchoalveolar lavage samples using genotypic and phenotypic methods. Adv Biomed Res 2018; 7(1): 66.
  12. Mirhendi H, Makimura K, Khoramizadeh M, Yamaguchi H. A one-enzyme PCR-RFLP assay for identification of six medically important Candida species. Nihon Ishinkin Gakkai Zasshi 2006; 47(3): 225-9.
  13. Hashemi H, Varshosaz J, Fazeli H, Sharafi SM, Mirhendi H, Chadeganipour M, et al. Rapid differential diagnosis of vaginal infections using gold nanoparticles coated with specific antibodies. Med Microbiol Immunol 2019; 208(6): 773-80.
  14. Mattede MdGS, Piras C, Mattede KDS, Ferrari AT, Baldotto LS, Assbu MSZ. Urinary tract infections due to Trichosporon spp. in severely ill patients in an intensive care unit. Rev Bras Ter Intensiva 2015; 27(3): 247-51.
  15. Bizuayehu H, Bitew A, Abdeta A, Ebrahim S. Catheter-associated urinary tract infections in adult intensive care units at a selected tertiary hospital, Addis Ababa, Ethiopia. PLoS One 2022; 17(3): e0265102.
  16. Berbudi A, Rahmadika N, Tjahjadi AI, Ruslami R. Type 2 diabetes and its impact on the immune system. Curr Diabetes Rev 2020; 16(5): 442-9.
  17. Bassiri Jahromi S, Khaksar AA. Deep-Seated Fungal Infections in Immunocompromised Patients in Iran before and after Treatments. Iranian Journal of Allergy, Asthma and Immunology 2005; 4(1): 27-32.
  18. Hoenigl M, Seidel D, Sprute R, Cunha C, Oliverio M, Goldman GH, et al. COVID-19-associated fungal infections. Nat Microbiol 2022; 7(8): 1127-40.
  19. Hughes S, Troise O, Donaldson H, Mughal N, Moore

    Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting. Clin Microbiol Infect 2020; 26(10): 1395-9.
  20. Prestel C, Anderson E, Forsberg K, Lyman M, de Perio MA, Kuhar D, et al. Candida auris outbreak in a COVID-19 specialty care unit—Florida, July–August 2020. Morbidity and Mortality Weekly Report 2021; 70(2): 56-7.
  21. Haghighatfard A, Abbasi S, Alijani P, Akbari FA, Rashidi H, Dehghan P. Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia in intensive care units in Isfahan, Iran. Curr Med Mycol 2022; 8(3): 30-4.
  22. Azad M, Chabavizadeh J, Dehghan P, Mohammadi R. The frequency of candiduria in hospitalized patients at nephrology department, Labbafinejad hospital, Tehran, Iran [in Persian]. J Isfahan Med Sch 2017; 35(450): 1364-9.
  23. Dehghan P, Bahmaei M, Mohammadi R, Chabavizadeh J, Mahaki B. Identification of Candida species isolated from candiduria patients using polymerase chain reaction-restriction fragment length polymorphism in Isfahan, Iran [in Persian]. J Isfahan Med Sch 2016; 34(381): 484-90.
  24. Khan S, Alam F, Azam A, Khan AU. Gold nanoparticles enhance methylene blue–induced photodynamic therapy: a novel therapeutic approach to inhibit Candida albicans biofilm. Int J Nanomedicine 2012; 7: 3245-57.
  25. Becker K, Almasri AS, Von Eiff C, Peters G, Heilmann C, Fegeler W. Systematic survey of nonspecific agglutination by Candida spp. in latex assays. Journal of clinical microbiology. 2007;45(4):1315-8.
  26. Khan MAR, Al Mamun MS, Habib MA, Islam AN, Mahiuddin M, Karim KMR, et al. A review on gold nanoparticles: biological synthesis, characterizations, and analytical applications. Results in Chemistry 2022; 4: 100478.
  27. Einloo A, Dehghan P, Saluti M, Mirzaahmadi S. Specific identification of candida glabrata via colorimetric assay based on gold nanoparticles [in Persian]. J Isfahan Med Sch 2015; 33(325): 231-41.
  28. Mussaie Z, Yousofi-Darani H, Hashemi H, Zareie I, Dehghan P. Evaluation of Rapid diagnosis of candidemia by agglutination test using gold nanoparticles [in Persian]. J Isfahan Med Sch 2022; 40(668): 248-55.
  29. Hu S, Kang H, Gu F, Wang C, Cheng S, Gong W, et al. Rapid detection method for pathogenic Candida captured by magnetic nanoparticles and identified using SERS via AgNPs+. Int J Nanomedicine 2021; 16: 941-50.
  30. Suzuki K, Nakase K, Kyo T, Kohara T, Sugawara Y, Shibazaki T, et al. Fatal Trichosporon fungemia in patients with hematologic malignancies. Eur J Haematol 2010; 84(5): 441-7.
Journal of Isfahan Medical School
Volume 42, Issue 766
2nd Week, July
July and August 2024
Pages 369-376

Files

History

  • Receive Date: 09 April 2024
  • Accept Date: 24 July 2024

Share

How to cite

Statistics